Medication education
Naltrexone and liver safety: what to know
Liver safety is one of the biggest questions people ask. The answer is more reassuring than many people expect, with the right clinical screening.
By Justine Fowey, Alcohol Specialist
The short answer
Naltrexone has liver warnings, which is why clinical screening matters. But at standard doses used for alcohol-related care, serious liver injury appears rare. The high-dose liver concern often cited comes from much higher dosing, such as 300 mg/day, not the typical 50 mg/day range used in many alcohol-treatment studies.
A licensed clinician reviews every assessment. Takes 60 seconds.
"Will this hurt my liver?" is one of the most important questions someone can ask before taking naltrexone. It deserves a direct answer, not a dismissive one.
The reassuring part is that for appropriate patients, standard-dose naltrexone is commonly used by clinicians and is supported by medical literature. The careful part is that liver history, current health, medications, opioid use, and drinking pattern all matter. That is why Onir starts with a clinical review.
Why naltrexone has liver warnings
Naltrexone is processed by the body, and liver safety has been studied for decades. LiverTox notes that naltrexone has been associated with low rates of serum enzyme elevations during therapy and rare instances of clinically apparent liver injury.
That language matters. It does not mean "zero risk." It means the risk needs to be understood in context and screened for appropriately.
The dose context matters
Many alcohol-related studies and clinical uses involve oral naltrexone around 50 mg/day. The high-dose liver concern people sometimes find online often traces back to much larger doses. A high-dose obesity trial used 300 mg/day and reported hepatotoxicity at that dosage.
That is not the dose Onir is typically built around. Onir's clinical team evaluates whether medication is appropriate and what dosing makes sense. The point of the assessment is to avoid one-size-fits-all prescribing.
Alcohol itself is a liver risk
It is also important to compare the medication concern with the current pattern. Heavy drinking and repeated binge drinking can be far more damaging to the liver over time than the standard-dose medication many people are worried about.
That does not mean everyone should take naltrexone. It means that for someone drinking more than they want, reducing alcohol exposure may be one of the more meaningful liver-protective steps available. A clinician can help evaluate that tradeoff.
Who needs extra caution
People with liver disease, abnormal liver tests, hepatitis history, heavy current drinking, other medications, or complex medical histories should be reviewed carefully. People taking opioids or who may need opioid pain medication also need specific screening because naltrexone blocks opioid receptors.
This is exactly why Onir does not simply ship medication because someone clicks a button. A licensed clinician reviews the assessment first.
The Onir way to think about liver safety
The question is not "Is medication good or bad?" The better question is: "Given my health, my drinking pattern, and my goals, is clinician-guided support appropriate for me?"
If the answer is no, the clinical review fee is refunded. If the answer is yes, the clinician can help you understand the plan, including safety considerations.
The bottom line
Liver safety is a real topic, but it should not be reduced to fear. Standard-dose naltrexone has a long clinical history, serious liver injury appears rare, and the bigger liver risk for many people is ongoing heavy drinking. The assessment exists so a clinician can review your situation specifically.
References
See if Onir is a fit — reviewed by a licensed clinician
A licensed U.S. clinician reviews your written assessment. No video call. Refunded if you are not approved.
60 seconds · 11 questions · Fully refunded if you're not approved